Patent Assignment
Reel/Frame 062078/0276
Security Agreement (Second Lien)
Recorded: 2022-11-04
Pages: 15
Assignors
BAUSCH HEALTH COMPANIES INC.
Executed: 2022-10-31
BAUSCH HEALTH IRELAND LIMITED
Executed: 2022-10-31
SOLTA MEDICAL IRELAND LIMITED
Executed: 2022-10-31
Assignee
THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
240 GREENWICH STREET, NEW YORK, NEW YORK, 10286
Covered Properties
(160)
Guanylate Cyclase Receptor Agonists for the Treatment of Tissue Inflammation and Carcinogenesis
Controlled Release Dosage Forms
Methods for Effecting Regression of Tumor Mass and Size in a Metastasized Pancreatic Tumor
Modified Release Tablet of Bupropion Hydrochloride
Modified Release Formulations of a Bupropion Salt
Alpha Hydroxy Acid Sustained Release Formulation
Teeth Whitening Composition and Methods
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Modified Release Formulations of a Bupropion Salt
Bupropion Hydrobromide and Therapeutic Applications
Bupropion Hydrobromide and Therapeutic Applications
Modified-Release Formulations of a Bupropion Salt
Methods and Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Method for Stabilizing Polypeptides Lacking Methionine
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Controlled Release Dosage Forms
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Photopolymerization Material for Gums Isolation
Bupropion Hydrobromide Polymorphs
Bupropion Hydrobromide and Therapeutic Applications
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
Compositions and Methods for Treating Diseases of the Nail
Patent:
8,039,494 →
Application:
12/803,848 →
Granular Sustained Release Preparation and Production Thereof
Stereoselective Synthesis of Metyrosine
Suspension Containing Micronized Benzoyl Peroxide
Methods and Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Compositions and Methods for Treating Diseases of the Nail
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Method of Inhibiting Bile Acid Absorption by Administering An Agonist of a Guanylate Cyclase Receptor
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Bupropion Hydrobromide Polymorphs
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Compositions for Increasing Solubility of Azole Drug Compounds That Are Poorly Soluble in Water
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Compositions and Methods for Treating Diseases of the Nail
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Process of Preparing Guanylate Cyclase C Agonists
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Agonists of Guanylate Cyclase and Their Uses
Compositions Useful For The Treatment Of Gastrointestinal Disorders
Agonists Of Guanylate Cyclase And Their Uses
Kinetin/Zeatin Topical Formulation
Agonists of Guanylate Cyclase Useful For the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Stereoselective Synthesis of Metyrosine
Modified Release Formulations Of A Bupropion Salt
Compositions and Methods for Treating Diseases of the Nail
Stabilized Efinaconazole Compositions
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Anti-Infective Methods, Compositions, and Devices
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Agonists of Guanylate Cyclase Useful for the Treatment of Hypercholesterolemia, Atherosclerosis, Coronary Heart Disease, Gallstone, Obesity and Other Cardiovascular Diseases
Compositions and Methods for Treating Diseases of the Nail
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Formulations of Calcium and Phosphate for Oral Inflammation
Compositions and Methods for Teeth Whitening
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Topical Compositions and Methods for Treating Psoriasis
Compositions Useful for the Treatment of Gastrointestinal Disorders
Compositions and Methods for Treating Diseases of the Nail
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Agonists of Guanylate Cyclase and Their Uses
Process of Preparing Guanylate Cyclase C Agonisys
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Kinetin/Zeatin Topical Formulation
Stabilized Efinaconazole Compositions
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Agonists of Guanylate Cyclase and Their Uses
Compositions and Methods for Treating Diseases of the Nail
Compositions and Methods for Treating Diseases of the Nail
Topical Compositions and Methods for Treating Psoriasis
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Kinetin/Zeatin Topical Formulation
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Formulations and Methods for Treating Ulcerative Colitis
Topical Pharmaceutical Compositions for Treating Skin Conditions
Compositions and Methods for Treating Diseases of the Nail
Agonists of Guanylate Cyclase and Their Uses
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Pharmaceutical Formulations Containing Corticosteroids for Topical Administration
Topical Compositions and Methods for Treating Skin Diseases
Topical Compositions and Methods for Treating Skin Diseases
Application:
16/179,576 →
Publication:
US 2019/0133943
Multidose Package, Course and Method of Treatment for Delivering Predetermined Multiple Doses of a Pharmaceutical
Anti-Infective Methods, Compositions, and Devices
Topical Pharmaceutical Compositions for Treating Skin Conditions
Polymeric Emulsion Delivery Systems
Stabilized Efinaconazole Formulations
Agonists of Guanylate Cyclase and Their Uses
Encrypted Memory Device
Methods and Apparatus for Pumping Coolant to an Energy Delivery Device
Pain Mitigation by Mechanical Stimulation When Treating Tissue with Electromagnetic Energy
Redundant Traces for Flexible Circuits Used in an Energy Delivery Device
Methods for manufacturing phenoxyethanol
Compositions and Methods for Treating Diseases of the Nail
Topical Compositions and Methods for Treating Acne Vulgaris
Application:
16/822,831 →
Publication:
US 2020/0297684
Topical Pharmaceutical Formulations Containing a Low Concentration of Benzoyl Peroxide in Suspension in Water and a Water-Miscible Organic Solvent
Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
Application:
16/882,059 →
Publication:
US 2020/0283480
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Topical Compositions
Anti-Infective Methods, Compositions, and Devices
Compositions and Methods for Treating Diseases of the Nail
Application:
17/092,473 →
Publication:
US 2021/0121572
Stabilized Efinaconazole Compositions as Antifungals
Topical Compositions and Methods for Treating Psoriasis
Agonists of Guanylate Cyclase and Their Uses
Application:
17/184,256 →
Publication:
US 2021/0379142
Formulations of Guanylate Cyclase C Agonists and Methods of Use
Application:
17/207,222 →
Publication:
US 2021/0205406
Ceramic Applicator for Transcutaneous Delivery of Energy
Microblade Structure and Method of Treating Tissue
Topical Compositions and Methods for Treating Psoriasis
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Application:
17/397,796 →
Publication:
US 2022/0119449
Ultra-Pure Agonists of Guanylate Cyclase C, Method of Making and Using Same
Liquid Oral Dosage Formulations of Methylnaltrexone
Application:
17/495,413 →
Publication:
US 2022/0096461
Use of Methylnaltrexone and Rifaximin for Treatment of Increased Gut Permeability or Associated Disorders
Application:
17/529,818 →
Publication:
US 2022/0175764
Compositions and Methods for Treating Diseases of the Nail
Redundant Traces for Flexible Circuits Used in an Energy Delivery Device
Methods of Treating Nonalcoholic Fatty Liver Disease (Nafld) Using Il-17RA Antibody
Application:
17/642,130 →
Publication:
US 2022/0380449
Methods of Using Rifamycin Sv for the Treatment of Sickle Cell Disease
Application:
17/687,534 →
Publication:
US 2022/0280478
Topical Pharmaceutical Compositions for Treating Skin Conditions
Application:
17/714,090 →
Publication:
US 2022/0226271
Topical Compositions and Methods for Treating Skin Diseases
Polymeric Emulsion Delivery Systems
Application:
17/747,938 →
Publication:
US 2023/0000768
Rifaximin Liquid Formulations
Application:
17/763,615 →
Publication:
US 2022/0378758
Topical Compositions Comprising a Macrolide Immunosuppressant
Application:
17/814,474 →
Publication:
US 2022/0362232
Methods and Apparatus for Pumping Coolant to an Energy Delivery Device
Topical Compositions
Electrode Assemblies with Non-Contact Temperature Sensing for Thermal Measurements
Ultrasonic Probes for Producing Multiple Cavitation Volumes
Application:
17/909,028 →
Publication:
US 2023/0087566
Light Therapy Device
Patent:
921,212 →
Application:
29/720,106 →
Light Therapy Device
Patent:
922,595 →
Application:
29/720,107 →
Light Therapy Device
Patent:
928,975 →
Application:
29/720,109 →
Access Device
Patent:
940,133 →
Application:
29/720,111 →
Vented Tip
Patent:
970,741 →
Application:
29/763,116 →
Light Therapy Device
Patent:
959,003 →
Application:
29/780,736 →
Display Screen with Animated Graphical User Interface
Patent:
959,458 →
Application:
29/782,587 →
Light Therapy Device
Patent:
959,004 →
Application:
29/788,730 →
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Notice of Succession of Agency
Jan 9, 2015
From: GOLDMAN SACHS LENDING PARTNERS, LLC
To: BARCLAYS BANK PLC, AS SUCCESSOR AGENT
Reel/Frame 034749/0689 →
Assignment of Assignor's Interest
Jan 15, 2015
From: CANYON PHARMACEUTICALS GROUP AG; CANYON PHARMACEUTICALS, INC.; CANYON PHARMACEUTICALS AG
To: MARATHON PHARMACEUTICALS, LLC
Reel/Frame 034723/0869 →
Assignment of Assignor's Interest
Jan 20, 2016
From: VALEANT HOLDINGS IRELAND
To: VALEANT HOLDINGS IRELAND, LUXEMBOURG BRANCH
Reel/Frame 037529/0212 →
Assignment of Assignor's Interest
Jan 20, 2016
From: VALEANT INTERNATIONAL BERMUDA
To: VALEANT HOLDINGS IRELAND
Reel/Frame 037529/0057 →
Assignment of Assignor's Interest
Jan 20, 2016
From: VALEANT HOLDINGS IRELAND, LUXEMBOURG BRANCH
To: VALEANT PHARMACEUTICALS LUXEMBOURG S.Á.R.L.
Reel/Frame 037529/0357 →
Assignment of Assignor's Interest
May 20, 2016
From: KLOX TECHNOLOGIES INC.
To: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
Reel/Frame 038654/0239 →
Security Interest
Jul 18, 2016
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSH & LOMB PHARMA HOLDINGS CORP.; DENDREON PHARMACEUTICALS, INC.
To: BARCLAYS BANK PLC
Reel/Frame 039380/0385 →
Security Interest
Jul 19, 2017
From: VALEANT PHARMACEUTICALS INTERNATIONAL, INC.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043045/0959 →
Security Interest
Sep 5, 2017
From: SYNERGY PHARMACEUTICALS INC.
To: CRG SERVICING LLC, AS AGENT
Reel/Frame 043488/0741 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
Security Interest
Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
Release of Security Interest
Mar 6, 2019
From: CRG SERVICING LLC
To: SYNERGY PHARMACEUTICALS INC.
Reel/Frame 048521/0005 →
Security Interest
Mar 11, 2019
From: BAUSCH HEALTH AMERICAS, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH HEALTH US, LLC; SOLTA MEDICAL, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 048556/0758 →
Merger
Apr 19, 2019
From: VALEANT INTERNATIONAL BERMUDA
To: VALEANT HOLDINGS IRELAND
Reel/Frame 048939/0764 →
Assignment of Assignor's Interest
Apr 22, 2019
From: VALEANT HOLDINGS IRELAND
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 048954/0900 →
Intellectual Property Security Agreement
Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
Assignment of Assignor's Interest
Sep 12, 2019
From: DOW PHARMACEUTICAL SCIENCES, INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 050358/0528 →
Assignment of Assignor's Interest
Oct 24, 2019
From: VALEANT PHARMACEUTICALS LUXEMBOURG S.Á.R.L.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 050817/0312 →
Assignment of Assignor's Interest
Apr 9, 2020
From: SYNERGY PHARMACEUTICALS INC.
To: BAUSCH HEALTH IRELAND LIMITED
Reel/Frame 052358/0134 →
Security Interest
Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
Security Interest
Jun 13, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON
Reel/Frame 060346/0705 →
Security Agreement (First Lien)
Oct 4, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061595/0066 →
Security Agreement (Second Lien)
Oct 5, 2022
From: BAUSCH HEALTH US, LLC; BAUSCH HEALTH AMERICAS, INC.; MEDICIS PHARMACEUTICAL CORPORATION; ORAPHARMA, INC.
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061606/0468 →
Security Agreement (First Lien)
Nov 4, 2022
From: BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH IRELAND LIMITED; SOLTA MEDICAL IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 061882/0708 →
Security Interest
Feb 13, 2023
From: BAUSCH HEALTH COMPANIES INC.; VALEANT CANADA LP; VALEANT CANADA GP LIMITED; V-BAC HOLDING CORP.
To: THE BANK OF NEW YORK MELLON
Reel/Frame 062670/0260 →